Home » Topics » Regulatory » Patents

Patents
RSS

New KDM1A inhibitors synthesized at Hanmi Science

Aug. 24, 2020

Femtogenix discloses G-A crosslinking cytotoxic agents

Aug. 24, 2020

New CDK2/cyclin E inhibitors discovered at Pfizer

Aug. 24, 2020

Janssen presents new anti-influenza nucleosides

Aug. 24, 2020

BioWorld MedTech Patent Highlights: Week 33

From Current Patent Gazette

Aug. 21, 2020

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Esteve presents dual sigma1 and mu-opioid receptor ligands

Aug. 21, 2020

New opioid receptor ligands identified at Yangtze River Pharmaceutical

Aug. 21, 2020

Jiangsu Chia Tai Tianqing Pharmaceutical discovers HBV capsid assembly inhibitors

Aug. 21, 2020

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent ADORA2A/B antagonists

Aug. 21, 2020

Phosphodiesterase PDE3A and PDE3B inhibitors described by Bayer, The Broad Institute

Aug. 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...